Top compounds associated with response to TMOD1


Feature Type Standardized
Nominal ANOVA
mRNA Nilotinib FIMM pan-cancer AAC -0.037 0.8
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0073 0.8
mRNA foretinib CTRPv2 pan-cancer AAC -0.0078 0.8
mRNA Rapamycin CTRPv2 pan-cancer AAC -0.0072 0.8
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.007 0.8
mRNA myricetin CTRPv2 pan-cancer AAC -0.0081 0.8
mRNA CP724714 GDSC1000 pan-cancer AAC 0.0073 0.8
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0076 0.8
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC -0.0078 0.8
mRNA Bexarotene FIMM pan-cancer AAC -0.031 0.8
Download CSV